Treatment with Durvalumab May Lead to Pneumonitis

One-third of patients with locally advanced non-small cell lung cancer treated with durvalumab developed symptomatic pneumonitis.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news